Related Experiment Video
Updated: May 22, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Immunogene therapy.
Terry Lichtor1, Roberta P Glick
1Department of Neurological Surgery, Rush University Medical Center, Chicago, IL, USA. terry_lichtor@rush.edu
Advances in Experimental Medicine and Biology
|May 29, 2012
Summary
This study developed a novel DNA-based genomic vaccine using tumor DNA transferred into modified fibroblasts. This approach successfully stimulated a systemic antitumor immune response and prolonged survival in a preclinical breast cancer brain metastasis model.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Tumor antigens vary widely, necessitating broad immune targeting for effective cancer immunotherapy.
- Current immunotherapies often target single antigens, limiting efficacy against heterogeneous tumors.
- Genomic DNA vaccines offer a strategy to present a comprehensive array of tumor antigens.
Purpose of the Study:
- To develop and evaluate a DNA-based genomic vaccine for cancer immunotherapy.
- To assess the vaccine's ability to elicit a systemic antitumor immune response.
- To investigate the therapeutic potential in a preclinical model of brain metastasis.
Main Methods:
- Genomic DNA from a mouse breast cancer was transferred into a modified, highly immunogenic mouse fibroblast cell line.
- Fibroblasts were engineered to secrete immune-augmenting cytokines and express allogeneic MHC Class I determinants.
- The DNA vaccine was administered directly into the tumor bed in an animal model of breast cancer metastatic to the brain.
Main Results:
- The DNA vaccine stimulated a significant systemic cellular antitumor immune response, confirmed by in vitro assays.
- Treatment with the vaccine prolonged the survival of tumor-bearing mice.
- Immunity was mediated by CD8+, CD4+, and NK/LAK cells, with a notable deficiency in regulatory T cells after enriched vaccine administration.
Conclusions:
- DNA-based genomic vaccines are a promising strategy for eliciting broad antitumor immunity.
- This approach demonstrates potential for treating brain metastases and other cancers.
- Further exploration of DNA-based genomic vaccines for various brain tumors is warranted.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...